Fulcrum Therapeutics (FULC) P/E (2019 - 2026)
Fulcrum Therapeutics (FULC) P/E from Sep 30, 2019 to Jun 12, 2026. The TTM Fulcrum Therapeutics (FULC) P/E is -2.71. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Fulcrum Therapeutics (FULC)
| Year | P/E | Change |
|---|---|---|
| 2026 | -2.71 | -68.45% |
| 2025 | -8.61 | -53.92% |
| 2024 | -18.68 | +403.69% |
| 2023 | -3.71 | +27.46% |
| 2022 | -2.91 | -63.61% |
| 2021 | -8.00 | +85.36% |
| 2020 | -4.31 | -62.55% |
| 2019 | -11.52 | N/A |
Comparison Fulcrum Therapeutics (FULC) P/E with competitors
Fulcrum Therapeutics (FULC) P/E is -2.71.